DOMH
Dominari Holdings Inc.
NASDAQ · Financial Services · Financial - Capital Markets · US
$1.68
+1.20%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.67
From 52W high−69.23%
Volume61351.00
Market cap$40.73M
P/E (TTM)—
P/S (TTM)0.3x
Div yield44.20%
Key dataNov 4, 2026
Open
$1.67
From 52W high
−69.23%
Volume
61351.00
Market cap
$40.73M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.1x
P/E (TTM)
—
RSI (14)
32.3
MomentumView details →
1D Return
+1.20%
YTD Return
−66.97%
SummaryUpdated Jun 1, 2026
Dominari Holdings Inc. (NASDAQ:DOMH) is a biotechnology company founded in 1967 and headquartered in New York, New York. Originally incorporated as Aikido Pharma Inc., the company rebranded to its current name in December 2022. With a history spanning over five decades, Dominari has evolved from its early origins to focus on developing innovative small-molecule therapeutics for cancer treatment and antiviral applications. The company operates in the highly regulated and capital-intensive biotechnology sector, where drug development timelines typically span many years and require substantial investment before generating meaningful revenue.
Similar companies
Latest newsMore news →
New America Acquisition I Corp. agreed to pay Dominari Holdings Inc. $20,000 per month for office space and administrative services until its initial business combination or liquidation, whichever occurs first.20d agoSeveral Trump Organization executives returned to Cuba in recent months under the aegis of Dominari Holdings for meetings, after previously exploring real estate deals and registering the Trump trademark there in 2008.48d ago